Universal Health Services, Inc. (NYSE: UHS) announced it will report Q3 2026 after the market close on Oct. 26, 2026 and hold its earnings call on Oct. 27.
Universal Health Services (NYSE: UHS - Get Free Report) and Exagen (NASDAQ: XGN - Get Free Report) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, earnings, risk, profitability and dividends. Institutional and Insider Ownership 86.0% of Universal Health
Shares of Universal Health Services, Inc. (NYSE: UHS - Get Free Report) have been given a consensus recommendation of "Hold" by the eighteen research firms that are presently covering the company, MarketBeat Ratings reports. Twelve equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company.
State Street Corp cut its stake in shares of Universal Health Services, Inc. (NYSE: UHS) by 18.5% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,102,613 shares of the health services provider's stock after selling 476,776 shares during the period.
Sequoia Financial Advisors LLC raised its holdings in Universal Health Services, Inc. (NYSE: UHS) by 83.6% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 7,026 shares of the health services provider's stock after buying an additional 3,200 shares during the quarter.
Engineers Gate Manager LP grew its holdings in shares of Universal Health Services, Inc. (NYSE: UHS) by 840.2% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 10,643 shares of the health services provider's stock after acquiring an additional